Articles

A duo for single-cell sequencing

TTP Labtech/UC San Diego collaboration accelerates single-cell genomics research
Written byMel J. Yeates
| 3 min read

CAMBRIDGE, U.K. & SAN DIEGO—TTP Labtech Ltd, a global designer and developer of automated instrumentation and consumables for life-sciences applications, along with the University of California, San Diego (UCSD), have announced that a collaboration between them has resulted in a new workflow for single-cell sequencing that reduces the cost of sample preparation by as much as 90 percent. The workflow was developed through the combination of UCSD’s expertise in genomics and the use of TTP Labtech’s mosquito liquid handlers, which can pipette nanoliter to microliter volumes with high accuracy and reproducibility, to miniaturize and automate the process.

The article was published in the Journal of Laboratory Automation, and is entitled “Miniaturization Technologies for Efficient Single-Cell Library Preparation for Next-Generation Sequencing.”

Dr. Soheila Vaezeslami, senior field application scientists at TTP Labtech, tells DDNews that this collaboration began in early January 2015 “right after the install of the instrument,” adding that “The article became the number one most-read article of the month for the September 2016 issue of JALA.”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue